Generics - Pharmaceutical

Filter

Current filters:

Pharmaceutical

Popular Filters

201 to 225 of 517 results

Julphar inaugurates drug-making plant in Ethiopia; discusses UAE drug prices

10-02-2013

In recognition of the economic importance of Africa and the need for increasingly sophisticated pharmaceutical…

GenericsJulpharPharmaceuticalPricingProductionRest of the World

Shire settles with Impax on Adderall XR authorized generic; initiates Ph III ABH001 study

10-02-2013

Ireland-based drugmaker Shire (LSE: SHP) says it has settled all pending litigation with Impax Laboratories…

ABH001Adderall XRDermatologicalsGenericsImpax LaboratoriesLegalNeurologicalNorth AmericaPharmaceuticalResearchShire

Teva Pharma's 4th-qtr financials just misses forecasts

08-02-2013

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) reported results for the fourth quarter 2012,…

FinancialGenericsPharmaceuticalTeva Pharmaceutical Industries

MEPS vote for access to cheaper generics drugs in Europe; mixed industry reaction

07-02-2013

European patients should have quicker access to cheaper "generic" medicines, according to Members of…

EuropeGenericsLegalPharmaceuticalPricingRegulation

Russian government to restrict sale of generics in national market

05-02-2013

The Russian government is considering restricting the sales of generics in the national market, through…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulation

Pharmaceutical manufacturing in China worth $78.8 billion in 2012, says IBISWorld

04-02-2013

Revenue for the pharmaceutical manufacturing industry in China is expected to increase at an annualized…

Asia-PacificGenericsPharmaceuticalProduction

US federal judge approves consent decree with Boehringer's Ben Venue Labs

03-02-2013

The US Food and Drug Administration announced today that a federal judge has approved a consent decree…

Ben Venue LabsBoehringer IngelheimGenericsLegalPharmaceuticalProductionRegulation

Stada Arz extends generics deal with Omega Pharma; Omega appointments

03-02-2013

German drugmaker Stada Arzneimittel's (SAZ: GR) Belgian subsidiary, Eurogenerics, and the pharmaceutical…

EuropeGenericsManagementMarkets & MarketingOmega PharmaPharmaceuticalSTADA Arzneimittel

EU Commission sends antitrust complaint to Johnson & Johnson and Novartis

01-02-2013

The European Commission has informed US health care giant Johnson & Johnson (NYSE: JNJ) and Swiss drug…

DuragesicEuropefentanylGenericsJanssen-CilagJohnson & JohnsonLegalMarkets & MarketingNeurologicalNovartisPatentsPharmaceuticalSandoz

Pfizer prevails in Rapamune patent dispute with Watson

01-02-2013

Global pharma behemoth Pfizer (NYSE: PFE) says that the US District Court for the District of Delaware…

ActavisGenericsImmunologicalsLegalNorth AmericaPatentsPfizerPharmaceuticalRapamuneWatson Pharmaceuticals

European Commission enforcement action in pharmaceutical sector following sector inquiry

31-01-2013

Following its competition inquiry into the pharmaceutical sector of 2008/2009, the European Commission…

DuragesicEuropeGenericsJohnson & JohnsonLundbeckMarkets & MarketingPatentsPharmaceuticalServier

US pharma organizations work together to foster supply chain security and integrity

31-01-2013

The 100th meeting of the USA-based National Conference of Pharmaceutical Organizations (NCPO) - consisting…

BiotechnologyGenericsHealthcareMarkets & MarketingNorth AmericaPharmaceutical

Indian pharmaceuticals market led by Ranbaxy in terms of revenue

31-01-2013

The Indian pharmaceutical market is the world's third-largest in terms of volume and stands 14th in terms…

Asia-PacificBioconBiotechnologyGenericsMarkets & MarketingPanacea BiotecPharmaceuticalRanbaxy LaboratoriesSerum Institute of India

ScinoPharm and Foresee Pharma set up JV for novel oncological peptide drugs

31-01-2013

Taiwanese drugmaker ScinoPharm (TWSE: 1789) and Foresee Pharmaceuticals, a Delaware, USA-based spin-out…

Asia-PacificForesee PharmaceuticalsGenericsleuprolideOncologyPharmaceuticalProductionResearchScinoPharm

South Africa's drugmakers bemoan low medicine price hikes

27-01-2013

South Africa's Department of Health announced last week that pharmaceutical companies will be allowed…

Adcock IngramAspen PharmacareGenericsPharmaceuticalPricingRest of the World

Federation of African Pharmaceutical Manufacturers Associations to be launched

22-01-2013

In an effort to further develop and strengthen local production of pharmaceutical produce in Africa,…

GenericsHealthcarePharmaceuticalProductionRest of the World

EU inks framework for a close collaboration with Israel, inc pharma products

21-01-2013

The European Medicines Agency announced yesterday that s legal framework for a close collaboration between…

EuropeGenericsPharmaceuticalRegulationRest of the World

FTC Study finds big rise in US patent settlements; challenged by GPhA

21-01-2013

During the 2012 fiscal year, the number of potentially anticompetitive patent dispute settlements - also…

GenericsLegalNorth AmericaPatentsPharmaceutical

GlobalData views potential of Pfizer's rumored acquisition of Strides' Agila unit

20-01-2013

As drug makers continue to jostle for market share and deal with declining revenues from their off-patent…

Agila SpecialitesGenericsMergers & AcquisitionsPfizerPharmaceuticalStrides Arcolab

Patent cliff: one drugmaker's sorrow is another one's joy

20-01-2013

The patent cliff has seen many drug majors lose their exclusivity on blockbuster drugs to generic makers…

DilantinGenericsLystedaMarkets & MarketingMylan LaboratoriesNorth AmericaPatentsPharmaceuticalWatson Pharmaceuticals

Study on generic HIV drugs prompts AHF to demand Gilead cuts ARV prices

16-01-2013

A new study published in the Annals of Internal Medicine that provides a snapshot of a simplified cost/benefit…

Anti-viralsAtriplaGenericsGilead SciencesNorth AmericaPharmaceuticalPricingStribild

Daiichi Sankyo and Ranbaxy combine business operations in Thailand

16-01-2013

Japanese pharma major Daiichi Sankyo (TYO: 4568) and its 64%-owned affiliate Ranbaxy Laboratories (AB:…

Asia-PacificDaiichi SankyoGenericsManagementMarkets & MarketingPharmaceuticalRanbaxy Laboratories

Indian govt plans compulsory licences for trastuzumab, ixabepilone and dasatinib

15-01-2013

The Indian government's move to issue compulsory licences to three more patented cancer drugs has left…

Asia-PacificAvastinBristol-Myers SquibbGenericsIxempraOncologyPatentsPharmaceuticalRocheSprycel

201 to 225 of 517 results

Back to top